HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xia Li Selected Research

clitocine

10/2016Clitocine potentiates TRAIL-mediated apoptosis in human colon cancer cells by promoting Mcl-1 degradation.
12/2014Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
5/2014Clitocine targets Mcl-1 to induce drug-resistant human cancer cell apoptosis in vitro and tumor growth inhibition in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xia Li Research Topics

Disease

407Neoplasms (Cancer)
12/2022 - 01/2002
74Inflammation (Inflammations)
02/2022 - 03/2005
60Breast Neoplasms (Breast Cancer)
11/2021 - 09/2007
57Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2022 - 01/2003
48Neoplasm Metastasis (Metastasis)
03/2022 - 01/2002
47Infections
12/2022 - 07/2002
42Carcinogenesis
12/2022 - 11/2009
39Hepatocellular Carcinoma (Hepatoma)
08/2022 - 07/2006
39Rheumatoid Arthritis
01/2022 - 02/2005
35Type 2 Diabetes Mellitus (MODY)
03/2022 - 01/2003
28Glioma (Gliomas)
08/2022 - 01/2002
28Alzheimer Disease (Alzheimer's Disease)
01/2022 - 08/2003
25Fibrosis (Cirrhosis)
05/2022 - 03/2004
25Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 09/2007
22Autoimmune Diseases (Autoimmune Disease)
10/2022 - 06/2010
22Hypoxia (Hypoxemia)
01/2022 - 10/2008
21Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 04/2005
21Lung Neoplasms (Lung Cancer)
01/2022 - 05/2013
21Prostatic Neoplasms (Prostate Cancer)
10/2021 - 10/2008
20Latent Autoimmune Diabetes in Adults
08/2022 - 01/2003
19Cognitive Dysfunction
01/2022 - 02/2003
19Stroke (Strokes)
01/2022 - 04/2007
19Obesity
08/2021 - 12/2005
18Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 12/2009
18Myocardial Infarction
01/2022 - 03/2005
18Carcinoma (Carcinomatosis)
01/2021 - 04/2009
17Brain Ischemia (Cerebral Ischemia)
01/2021 - 04/2007
17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2006
16Pain (Aches)
06/2022 - 10/2008
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 07/2005
16Leukemia
01/2022 - 01/2004
15Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 06/2010
15Insulin Resistance
03/2022 - 08/2004
15Ischemic Stroke
01/2022 - 07/2010
15Ischemia
01/2022 - 08/2004
15Glioblastoma (Glioblastoma Multiforme)
01/2021 - 11/2009
14Pancreatic Neoplasms (Pancreatic Cancer)
12/2022 - 12/2004
14Disease Progression
12/2022 - 08/2004
14Stomach Neoplasms (Stomach Cancer)
12/2021 - 01/2010
13Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 08/2008
13COVID-19
04/2022 - 08/2020
13Body Weight (Weight, Body)
01/2021 - 03/2004
12Atherosclerosis
01/2022 - 05/2007
12Reperfusion Injury
01/2022 - 01/2015
12Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2016
12Hyperglycemia
10/2020 - 09/2008
11Necrosis
05/2022 - 10/2007
11Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 12/2003
11Dementia (Dementias)
12/2021 - 10/2013
11Substance-Related Disorders (Drug Abuse)
11/2021 - 12/2005
11Adenocarcinoma of Lung
04/2021 - 11/2015

Drug/Important Bio-Agent (IBA)

121Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2007
84Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2007
83MicroRNAs (MicroRNA)IBA
12/2022 - 10/2011
82Pharmaceutical PreparationsIBA
07/2022 - 03/2004
61Messenger RNA (mRNA)IBA
08/2022 - 12/2004
61Long Noncoding RNAIBA
06/2022 - 07/2014
50Biological ProductsIBA
12/2022 - 01/2004
45Glucose (Dextrose)FDA LinkGeneric
10/2022 - 12/2005
44CytokinesIBA
01/2022 - 08/2004
33Insulin (Novolin)FDA Link
10/2022 - 01/2003
29LipidsIBA
09/2022 - 05/2007
27Transcription Factors (Transcription Factor)IBA
12/2022 - 09/2008
27Therapeutic UsesIBA
03/2022 - 04/2007
26RNA (Ribonucleic Acid)IBA
01/2022 - 10/2002
24DNA (Deoxyribonucleic Acid)IBA
07/2022 - 10/2006
24AutoantibodiesIBA
01/2022 - 10/2003
19Circular RNAIBA
08/2022 - 01/2019
19Interleukin-6 (Interleukin 6)IBA
06/2022 - 09/2008
18Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2022 - 01/2003
18AntigensIBA
01/2022 - 07/2006
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 06/2008
16Peptides (Polypeptides)IBA
01/2022 - 06/2005
16EnzymesIBA
01/2021 - 09/2013
15LigandsIBA
09/2022 - 12/2011
15C-PeptideIBA
01/2022 - 01/2003
15Neuroprotective AgentsIBA
01/2022 - 04/2007
14Caspase 3 (Caspase-3)IBA
05/2022 - 04/2009
14Blood Glucose (Blood Sugar)IBA
02/2022 - 08/2004
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 07/2005
14Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2010
13Interleukin-17 (Interleukin 17)IBA
01/2022 - 02/2010
13Competitive Endogenous RNAIBA
01/2022 - 09/2015
13Small Interfering RNA (siRNA)IBA
05/2021 - 10/2008
13C-Reactive ProteinIBA
04/2021 - 01/2005
12LeptinIBA
11/2022 - 01/2013
12AntioxidantsIBA
07/2022 - 03/2014
12Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 05/2002
12CalciumIBA
01/2022 - 03/2005
12Silicon Dioxide (Silica)FDA LinkGeneric
01/2022 - 06/2013
12InterleukinsIBA
01/2022 - 01/2010
12Glutamic Acid (Glutamate)FDA Link
01/2022 - 07/2010
12Apolipoproteins E (ApoE)IBA
01/2021 - 08/2003

Therapy/Procedure

160Therapeutics
11/2022 - 01/2007
43Drug Therapy (Chemotherapy)
05/2022 - 08/2007
43Immunotherapy
03/2022 - 07/2006
21Neoadjuvant Therapy
08/2021 - 01/2010
15Radiotherapy
01/2022 - 08/2007
14Glycemic Control
04/2022 - 09/2008
12Transplantation
11/2022 - 01/2012